A Prospective Multicenter Trial Evaluating Helios Biodegradable Polymer SES Safety and Effectiveness in CAD Treatment
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 800 participants.
Also called NCT01880879
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 800 participants
- Sponsor
- Registry
-
NCT01880879
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT01880879. Allocation not applicable; no masking; primary purpose treatment. Start 2013-01 (registry gives no type); primary completion 2015-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Prospective Multicenter Trial Evaluating Helios Biodegradable Polymer SES Safety and Effectiveness in CAD Treatment
- Acronym
- Pro-HOPE
- Condition
- Coronary Artery Disease
- Intervention (Device)
- helios stent
- Lead sponsor
- Kinhely Bio-tech Co., Ltd.
- Collaborator
- RenJi Hospital
- Collaborator
- Peking University
Record details
- Record id
cardio:ct-nct01880879- Content hash
8fb5581a97128fc4fab089b3f7a484d5385cf9678a4428e6300d03f99ec0eb31